A detailed history of Baird Financial Group, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 22,289 shares of INSM stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,289
Holding current value
$1.76 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$66.29 - $76.63 $1.48 Million - $1.71 Million
22,289 New
22,289 $1.54 Million
Q1 2022

May 13, 2022

SELL
$20.42 - $28.13 $156,233 - $215,222
-7,651 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $171,841 - $225,474
7,651 New
7,651 $211,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.7B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.